L & S Advisors Inc Incyte Corp Transaction History

L & S Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$60.85 - $83.98 $342,646 - $472,891	-5,631 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $230,325 - $280,017	2,773 Added 97.03%	5,631 $469,000
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $307,063 - $382,681	-3,282 Reduced 53.45%	2,858 $271,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $241,767 - $306,268	2,215 Added 56.43%	6,140 $717,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,925	3,925 $494,000

642

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.